Case number planning, which is calculated to match the study design, is an important success factor for precise study results. Our colleague Christiane Lober has studied the methods.
"Medicine should not only give years to life, but also life to the years." Georg Christoph Lichtenberg
The study protocol has been released and submitted to the Ethics Committee. The first trial phase of PASSPORT-HF is almost completed.
IHF GmbH is present at the DGK Herztage in Berlin. You will find us at exhibition stand 4 at the foyer of the Maritim Hotel Berlin.
"Scramble of data": This was the title Christiane Lober, statistician at IHF GmbH, used to present the database system she developed at the 23rd SAS Users in Research and Development Conference in Berlin.
First patient enrolled in the REBOOT PARADOX clinical trial at Ludwigs-Maximilians-University Munich.
The Annual DGK Conference gave us the opportunity to take an in-depth look at the current prospects and desiderata in cardiovascular research.
Join us at the Annual DGK Conference in Mannheim. We will be at the Congress Center Rosengarten, Level 0, Stand 103.
Having received a positive vote from the ethics committee is great because it means that we can get started with the study straight away.
We live and breathe teamwork. This is now reflected in our new image.